Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Researchers created small amber particles for use in bioactive and biocompatible fibers that could help with skin and hair restoration and are safe for infant clothing.

The TrichoConcept™ line is effective for personalized hair loss treatments.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Resistance exercise improves body image in breast cancer survivors.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Farmácias de manipulação precisam melhorar o controle de qualidade do Minoxidil.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

Minoxidil in FOAMIL is stable for at least 180 days at various concentrations.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

No treatment fully prevents hair loss from chemotherapy yet.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

The method effectively detects banned substances in urine for sports antidoping.

Cimetidine cream shows potential for treating warts and female-pattern hair loss.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.